Showing results (121-130 of 465) with videos related to

Sort By:
Pageof 47
The Journal of Urology|March 7, 2006
The expression of transcription factor activating transcription factor 3 in the human prostate and its regulation by androgen in prostate cancerAlexandre E Pelzer, Jasmin Bektic, Petra Haag, et al.
Cancer Cytopathology|June 3, 2019
Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancerEmanuela Trenti, Carolina D'Elia, Christine Mian, et al.
Urologia Internationalis|June 27, 2021
Geriatric Patients and Symptomatic Urinary Tract Infections: Analysis of Bacterial Range and Resistance Rates at a 3rd Level of Care Hospital in GermanyAnn-Sera Manseck, Wolfgang Otto, Marco Schnabel, et al.
International Journal of Cancer|February 18, 2010
Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidyChristine Wasylyk, Alberto Zambrano, Chunhua Zhao, et al.
Cancer Cytopathology|January 25, 2020
Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancerEmanuela Trenti, Stefan Pycha, Christine Mian, et al.
Future Oncology (London, England)|September 17, 2011
The enlightenment of bladder cancer treatment: origin and progress of photodynamic diagnosisWolfgang Otto, Maximilian Burger, Hans-Martin Fritsche, et al.
BJU International|April 26, 2008
Does the current World Health Organization classification predict the outcome better in patients with noninvasive bladder cancer of early or regular onset?Maximilian Burger, Stefan Denzinger, Wolf-Ferdinand Wieland, et al.
Expert Review of Vaccines|June 23, 2011
Vaccination therapy in renal cell carcinoma: current position and future options in metastatic and localized diseaseSabine Brookman-May, Maximilian Burger, Wolf F Wieland, et al.
European Urology|July 13, 2007
Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?Stefan Denzinger, Hans-Martin Fritsche, Wolfgang Otto, et al.
Translational Andrology and Urology|March 15, 2021
Epidemiology and therapy of symptomatic lymphoceles after robot-assisted radical prostatectomy (RARP)Christopher Goßler, Johannes Hillinger, Maximilian Burger, et al.
Pageof 47